Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q1 2025 · 10-Q
Revenue$35.95M$35.95M−30.2% vs Q1 2024 Net Income-$3.49M-$3.49MN/M vs Q1 2024 EPS Diluted-$0.04-$0.04N/M vs Q1 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flow-$246,000N/M Free Cash Flowderived-$2,860,000N/M Margins · derivedGross margin19.6%
Operating margin-15.8%+3.3 pt vs Q1 2024
Net margin-9.7%−1.5 pt vs Q1 2024
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end